Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9- cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3570-3576

  Elstner, Elena ^a   Linker Israeli, Mariana ^a   Umiel, Tehila ^a   Le, Jennifer ^a   Grillier, Isabelle ^a   Said, Jonathan ^a   Shintaku, I Peter ^a   Krajewski, Stanislaw ^b   Reed, John C ^b   Binderup, Lise ^c   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

^c Deparment of Biology   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; LEXACALCITOL; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER REGRESSION; CELL DIFFERENTIATION; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, SURFACE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CALCITRIOL; CELL DIFFERENTIATION; CELL DIVISION; CLONE CELLS; DRUG SYNERGISM; HL-60 CELLS; HUMANS; PHAGOCYTOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRETINOIN;

EID: 8044226035     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Warrell, R. P., Jr. Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood, 82: 1949-1953, 1993.
2. Heyman, R., Mangelsdorf, D., Dyck, J., Stein, R. B., Eichele, G., and Evans, R. M. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68: 397-406, 1992.
3. Levin, A., Strzenbecker, L., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., Kratzeisen, C., Rosenberger, M., Lovey, A., and Grippo, J. F. 9-cis retinoic acid stereoisomer binds and activates, the nuclear receptor RXR-α. Nature (Lond.), 335: 359-361, 1992.
4. Kizaki, M., Ikeda, Y., Tanosaki, R., Nikajama, H., Monkawa, M., Sakashita, A., and Koeffler, H. P. Effects of novel retinoic acid compound, 9-cis-retinoic acid, on proliferation, differentiation and expression of retinoic acid receptor RNA by HL-60 cells. Blood, 83: 3592-3599, 1993.
5. Sakashita, A., Kizaki, M., Pakkala, S., Schiller, G., Tsuroka, N., Tomosaki, R., Cameron, J. F., Dawson, M. I., and and Koeffler, H. P. 9-cis-Retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood, 81: 1009-1016, 1993.
6. Miller, W. H., Jr., Jakubowski, A., Tong, W. P., Miller, V. A., Rigas, J. R., Benedetti, F., Gill, G. M., Truglia, J. A., Ulm, E., Shirley, M., and Warrell, R. P., Jr. 9-cis retinoic acid induces complete remission but does not reverse clinically acquired retinoid resistance in acute promyelocytic leukemia. Blood, 85: 3021-3027, 1995.
7. Baker, A. R., McDonnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., Pike, J. W., Shine, J., and O'Malley, B. W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA, 85: 3294-3298, 1988.
8. 3 response clement. Leukemia Res., 19: 147-158, 1995.
9. Carlberg, C., Bendik, I., Wyss, A., Meier, E., Sturzenbecker, L. J., Grippo, J. F., and Hunziker, W. Two nuclear signalling pathways for vitamin D. Nature (Lond.), 361: 657-660, 1993.
10. Schrader, M., Bendik, I., Becker-André, M., and Carlberg, C. Interaction between retinoic acid and vitamin D signalling pathways. J. Biol. Chem., 268: 17830-17836, 1993.
11. Schrader, M., Müller, K. M., and Carlberg, C. Specificity and flexibility of vitamin D signaling. J. Biol. Chem., 269: 5501-5505, 1994.
12. 3 (VD) analog MC903, EB1089 and KH1060 activate the VD receptor. Homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. J. Steroid Biochem. Mol. Biol., 51: 137-142, 1994.
13. 3: in vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat. Rep., 69: 1399-1407, 1985.
14. Bar-Shavit, Z., Kahn, A. J., Stone, K. R., Trial, J., Hilliard, T., Reitsma, P., and Teitelbaum, S. L. Reversibility of vitamin D-induced human leukemia cell maturation. Endocrinology, 118: 679-686, 1986.
15. Studzinski, G. P., and Brelvi, Z. S. Changes in proto-oncogene expression associated with reversal of macrophage-like differentiation of HL-60 cells. J. Natl. Cancer Inst., 79: 67-76, 1987.
16. 3 analogues: a novel class of potent regulators cell growth and immune responses. Biochem. Pharmacol., 42: 1569-1575, 1991.
17. 3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood, 84: 1960-1968, 1994.
18. 3 analogs: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res., 55: 2822-2830, 1995.
19. Lennon, S. V., Martin, S. J., and Cotter, T. G. Dose-dependent induction of apoptosis in human tumor cell lines by widely diverging stimuli. Cell Prolif., 24: 203-214, 1991.
20. Martin, S. J., and Green, D. R. Apoptosis as a goal of cancer therapy. Curr. Opin. Oncol., 6: 616-621, 1994.
21. Nagy, L., Thornázy, V., Syka, P., Heyman, R., Chandraratna, R., and Davies, P. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol., 15: 3540-3551, 1995.
22. Collins, S. J., Gallo, R. C., and Gallagher, R. E. Continuous growth of human myeloid leukemic cells in suspension culture Nature (Lond.), 270: 347-349, 1977.
23. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., and Gallo, R. C. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J. Exp. Med., 149: 969-974, 1979.
24. Munker, R., Norman, A. W., and Koeffler, H. P. Vitamin D compounds effects on clonal proliferation and differentiation of human myeloid cells. J. Clin. Invest., 87: 424-430, 1986.
25. Martin, S. J., and Cotter, T. G. Apoptosis of human leukemia: induction, morphology, and molecular mechanisms. In: L. D. Tomei and F. D. Cope (eds.), Apoptosis II: Molecular Basis of Apoptosis in Disease, p 1. Cold Spring Harbor, NY Cold Spring Harbor Laboratory, 1994.
26. Sellins, K. S., and Cohen, J. J. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol., 139: 3199-3206, 1987.
27. Krajewski, S., Blomqvist, C., Franssila, K., Krajewska, M., Wasenius, V. M., Niskanen, E., Nordling, S., and Reed, J. C. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55: 4471-4478, 1995.
28. Territo, M. C., and Cline, M. J. Monocyte function in man. J. Immunol., 118: 187-192, 1977.
29. Berenbaum, M. C. What is synergy? Pharmacol. Rev., 41: 93-141, 1989.
30. Chen, Z-X., and Breitman, T. R. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy. Cancer Res., 54: 3494-3499, 1994.
31. Midland, M. M., Plumet, Y., and Okamura, W. H. Effect of C20 stereochemistry on the conformational profile of the side chains of vitamin D analogs. Bioorg. & Med. Chem. Lett., 3: 1799-1804, 1993.
32. Peleg, S., Sastry, M., Collinst, E., Bishop, Y. E., and Norman, A. W. Distinct conformational changes induced by 10-epi analogs of 1α,25-dihydroxyvitamin D3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem., 270: 3-8, 1995.
33. 3 and retinoic acid (all-trans or 9-cis). J. Steroid Biochem. Mol. Biol., 53: 431-441, 1995.
34. 3 co-operate to promote differentiation of the human promyeloid leukemia cell line HL60 to monocytes. Leukemia (Baltimore), 8: 806-815, 1994.
35. 3 results in differentiation towards neutrophils or monocytes or a failure to differentiate and apoptosis. Leukemia (Baltimore), 9: 410-418, 1995.
36. 3/retinoic acid induction of human promyelocytic cell enhanced phagocytic cell maturation and hybrid granulomonocytic phenotype. Cell Growth & Differ., 6: 493-503, 1995.
37. Hockenbery, D., Nufiez, G., Milliman, C., Schreiber, R. D., and Korsmeyer, S. J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348: 334-339, 1990.
38. Hockenbery, D. M. The bcl-2 oncogene and apoptosis. Semin. Immunol., 4: 413-420, 1992.
39. McDonnell, T. J., Deane, N., Platt, F. M., Nufiez, G., Jaeger, U., McKearn, J. P., and Korsmeyer, S. J. Bcl-2 immunoglobin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57: 79-88, 1989.
40. Oltvai, Z., Milliman, C., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
41. Martin, S. J., Bradley, J. G., Cotter, T. G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol., 79: 448-453, 1990.
42. Zhan, Q., Fan, S., Bae, I., Guillouf, C., Liebermann, D. A., O'Connor, P. M., Fornace, A. J., Jr. Induction of bax genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene, 9: 3743-3751, 1994.
43. 3 protects HL-60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp. Cell Res., 209: 367-374, 1993.